Dividend compounder review

BIIB

Biogen Inc · NASDAQ · US

Healthcare · Drug Manufacturers - General

Chart Factor Intelligence Back to Screener
Score47.50/100
Confidence82.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 17.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 17.5 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 8.0 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 5.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$1.3B
Free Cash Flow$2.0B
FCF Covers DividendUnknown
Debt / Equity0.35
P/E21.5
Revenue Growth 5Y-6.1%
Net Margin13.8%
ROE7.7%
Price vs Trend8.5%
3Y Return-29.7%
5Y Return-42.5%
CurrencyUSD
Warnings

Review flags

No usable dividend history found.
Dividend diary

Activity record

BIIB dividend review warning Warning · Warning

No usable dividend history found.